Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events

Technology appraisal guidance
Reference number: TA210
Published: 15 December 2010

TA210 Vascular disease - clopidogrel and dipyridamole: GE decision paper September 2013

TA210 Vascular disease - clopidogrel and dipyridamole: GE decision paper September 2013

TA210 Vascular disease - clopidogrel and dipyridamole: GE decision paper September 2013
23 September 2013
(123.81 Kb 36 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 18 September 2013